Retour sur lavenir.net
   UMICORE 23.820 € (+1,02 %)     KINEPOLIS GROUP 41.500 € (-0,12 %)     ARGENX SE 763.200 € (+1,25 %)     AZELIS GROUP 11.900 € (+2,59 %)     GIMV 44.650 € (-0,22 %)     SOFINA 247.400 € (+0,81 %)     ASCENCIO 52.400 € (-0,57 %)     CMB.TECH 14.040 € (-0,99 %)     UCB 223.100 € (-0,84 %)     D'IETEREN GROUP 183.300 € (-0,11 %)     EVS 28.350 € (-0,35 %)     TINC 11.280 € (-0,70 %)     XIOR 27.900 € (-0,18 %)     ELIA GROUP 131.900 € (-0,53 %)     SHURGARD 25.850 € (-0,58 %)     VGP 82.000 € (-1,56 %)     LOTUS BAKERIES 12 060.000 € (+5,42 %)     SOLVAY 26.780 € (+0,22 %)     DECEUNINCK 2.195 € (+0,69 %)     CARE PROPERTY INV. 12.600 € (+0,32 %)     KBC 127.900 € (+0,55 %)     BARCO 8.075 € (+0,44 %)     WDP 21.660 € (-0,73 %)     CIE BOIS SAUVAGE 303.000 € (0,00 %)     ACKERMANS V.HAAREN 264.800 € (-1,19 %)     DEME GROUP 167.000 € (+1,09 %)     FAGRON 22.550 € (+0,89 %)     VAN DE VELDE 29.900 € (-0,33 %)     COLRUYT 38.320 € (-0,93 %)     AB INBEV 72.860 € (-0,79 %)     RETAIL ESTATES 65.400 € (-1,21 %)     CENERGY 23.240 € (+0,52 %)     TUBIZE-FIN 190.600 € (-1,40 %)     AEDIFICA 69.250 € (-0,07 %)     BPOST 1.362 € (-10,63 %)     IMMOBEL 21.400 € (+0,47 %)     SYENSQO 80.450 € (+1,13 %)     CFE 12.050 € (-0,41 %)     ENERGYVISION 15.440 € (+0,13 %)     IBA 16.260 € (+1,63 %)     MELEXIS 72.000 € (+0,91 %)     VIOHALCO 18.100 € (+1,12 %)     JENSEN-GROUP 74.000 € (-14,75 %)     TITAN S.A. 51.250 € (-3,30 %)     GBL 78.050 € (-0,19 %)     ORANGE BELGIUM 22.000 € (0,00 %)     ONTEX GROUP 2.580 € (+2,99 %)     TESSENDERLO 21.550 € (-1,15 %)     ECONOCOM GROUP 1.480 € (-0,67 %)     EKOPAK 4.200 € (-0,47 %)     SOLVAC NOM(RETAIL) 78.500 € (-1,88 %)     KBC ANCORA 90.200 € (+0,33 %)     AGEAS 74.450 € (+0,34 %)     WERELDHAVE BELGIUM 53.000 € (+0,38 %)     ONWARD MEDICAL 2.380 € (-1,65 %)     PROXIMUS 6.275 € (-1,34 %)     NYXOAH 1.268 € (+10,07 %)     VASTNED 29.900 € (+0,17 %)     CAMPINE 206.000 € (0,00 %)     BREDERODE 103.000 € (+0,39 %)  
   SAINT GOBAIN 85.440 € (+0,85 %)     AMUNDI 96.750 € (-0,36 %)     SANOFI 75.310 € (+1,35 %)     COFACE 16.100 € (-0,19 %)     TOMTOM 4.042 € (+1,56 %)     X-FAB 7.030 € (+3,84 %)     MAROC TELECOM 9.000 € (+0,22 %)     UMG 15.565 € (+2,71 %)     SOITEC 122.500 € (+1,45 %)     PHILIPS KON 23.130 € (+0,70 %)     UNILEVER 54.650 € (-0,78 %)     ATOS GROUP 31.700 € (-0,13 %)     CARVOLIX 6.200 € (-1,90 %)     ENERGY SOLAR 1.400 € (+1,08 %)     MEDINCELL 24.500 € (-1,69 %)     AALBERTS NV 45.080 € (+0,54 %)     L'OREAL 385.900 € (-1,15 %)     S.E.B. 59.500 € (-0,67 %)     BONDUELLE 8.610 € (-1,37 %)     LUMIBIRD 27.000 € (+1,50 %)     ADYEN 930.300 € (-0,31 %)     PEUGEOT INVEST 57.500 € (+0,35 %)     LAKEFRONT BIOTHER. 23.340 € (+3,83 %)     ENGIE 26.720 € (+0,60 %)     LVMH 480.000 € (-0,30 %)     CSG 17.714 € (-8,02 %)     ABN AMRO BANK N.V. 39.730 € (-0,13 %)     SBM OFFSHORE 32.400 € (-7,69 %)     BUREAU VERITAS 28.360 € (-0,28 %)     AB SCIENCE 1.000 € (+24,07 %)     KERING 286.650 € (-1,07 %)     BOUYGUES 48.640 € (-1,12 %)     AKZO NOBEL 63.520 € (-0,06 %)     NANOBIOTIX 33.460 € (+0,78 %)     HEINEKEN 77.140 € (-0,87 %)     ALTAREA 100.400 € (-0,20 %)     REMY COINTREAU 46.600 € (+2,69 %)     RUBIS 33.400 € (+0,30 %)     KAUFMAN ET BROAD 25.250 € (+0,60 %)     TELEPERFORMANCE 70.000 € (+1,92 %)     HAFFNER ENERGY 0.456 € (-1,19 %)     2CRSI 27.600 € (-0,79 %)     SHELL PLC 38.390 € (-1,01 %)     LISI 67.200 € (+1,66 %)     TRIGANO 152.900 € (+1,12 %)     V LANSCHOT KEMPEN 65.250 € (-0,76 %)     TIKEHAU CAPITAL 17.020 € (+0,59 %)     HEINEKEN HOLDING 72.650 € (-1,29 %)     Coca-ColaEuropacif 92.900 € (-1,06 %)     UNIFY GROUP 1.862 € (-0,53 %)     POSTNL 0.911 € (-2,57 %)     ASML HOLDING 1 499.000 € (+0,33 %)     PHARMING GROUP 0.960 € (+1,52 %)     EXAIL TECHNOLOGIES 124.600 € (+0,08 %)     VETOQUINOL 72.600 € (+1,82 %)     CTP 14.680 € (-3,17 %)     TOTALENERGIES 74.090 € (-0,60 %)     CROSSJECT 1.498 € (-1,45 %)     RELX 30.840 € (+1,05 %)     VEOLIA ENVIRON. 35.190 € (+0,34 %)  
News Réglementées
29/06/2026 09:56

EQS-Adhoc: Management Board of FamiCord AG resolves on intended transfer of stock exchange listing from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange

EQS-Ad-hoc: FamiCord AG / Key word(s): Strategic corporate decision
Management Board of FamiCord AG resolves on intended transfer of stock exchange listing from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange

29-Jun-2026 / 09:56 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Management Board of FamiCord AG resolves on intended transfer of stock exchange listing from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange

Leipzig, 29 June 2026 – At its meeting held today, the Management Board of FamiCord AG (the “Company”) resolved to realign the stock exchange listing of the Company’s shares and to prepare a transfer from the regulated market (Prime Standard) to the Scale segment of the Open Market of the Frankfurt Stock Exchange.

To this end, the Company intends to apply, on the one hand, for the revocation of the admission of FamiCord AG’s shares to trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange pursuant to section 39 para. 2 of the German Stock Exchange Act (BörsG) and, on the other hand, for the inclusion of the Company’s shares in trading on the Scale segment of the Open Market of the Frankfurt Stock Exchange.

The decision is based on the newly created statutory option introduced by the Act to Strengthen Germany as a Financial Centre (Standortförderungsgesetz – StoFöG), which allows for a simplified transfer from the regulated market to an SME growth market. The Company is of the view that the Scale segment, as an SME growth market within the meaning of Article 33 of Directive 2014/65/EU, provides a suitable and appropriate trading framework for the shares of FamiCord AG.

In the opinion of the Management Board, the regulatory requirements and costs associated with the current listing on the regulated market (Prime Standard) are no longer proportionate to the related benefits for a company of FamiCord AG’s size. The transfer to the Scale segment is intended to reduce the Company’s administrative burden and enable it to allocate more resources to strengthening its operating business, while maintaining public tradability of its shares on a German stock exchange.

No new shares are intended to be issued in connection with the planned segment transfer. Accordingly, the Company will not receive any proceeds from the sale of securities as a result of the inclusion of its shares in the Scale segment.

Completion of the segment transfer remains subject, in particular, to the filing of the relevant applications and to the corresponding decisions and procedural steps of the Frankfurt Stock Exchange.

Notifying Person: Jakub Baran (CEO)

--- End of inside information according to Art. 17 MAR ---



End of Inside Information

Explanation, why the information directly concerns that issuer:

Contact: 
FamiCord AG
Ingo Middelmenne
Head of Investor Relations
Phone: +49 (0174) 9091190
Email: ingo.middelmenne@famicord.com

 

Company profile

FamiCord (formerly Vita 34) was founded in Leipzig in 1997 and today is by far the leading cell bank in Europe and the third largest worldwide. As the first private umbilical cord blood bank in Europe and a pioneer in cell banking, the company has since offered the collection, logistics, processing and storage of stem cells from umbilical cord blood, umbilical cord tissue and other postnatal tissues as a full-service provider for cryopreservation. The donor's own cells are either applicable directly as a medicine or constitute as a valuable starting material for medical cell therapy and are kept alive in the vapor of liquid nitrogen. Customers from about 50 countries have already provided for the health of their families with far over one million units of stored biological material at FamiCord. Furthermore, the Company is active in the area of Cell and Gene CDMO.


29-Jun-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:FamiCord AG
Perlickstr. 5
04103 Leipzig
Germany
Phone:+49(0341)48792-40
Fax:+49(0341)48792-39
E-mail:ir@famicord.com
Internet:www.famicord.com
ISIN:DE000A0BL849
WKN:A0BL84
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX
EQS News ID:2355854

 
End of AnnouncementEQS News Service

2355854  29-Jun-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière